Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab in Locally Advanced Esophageal Carcinoma
NCT01107639Phase 3Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- May 2010
- Primary completion
- Oct 2016
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 3 trial of KL-140 in esophageal carcinoma, sponsored by Swiss Group for Clinical Cancer Research. Started May 2010; status: completed.
02
Drugs
KL-140
03
Conditions
esophageal carcinoma
Beyond the preview
Go deeper on NCT01107639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01107639.